Loading...
Cell And Gene Therapy Tailwinds Will Drive Meaningful Long Term Upside Potential
AN
AnalystHighTarget
Not Invested
Community Contributor
Published
27 Dec 25
Views
3
27 Dec
US$1.06
AnalystHighTarget's Fair Value
US$9.00
88.2% undervalued intrinsic discount1Y
-52.9%7D
-2.8%1Y
-52.9%7D
-2.8%You can edit this narrative until Dec 28 12:10 AM. Then, changes will post as Updates.
Author's Valuation
US$988.2% undervalued intrinsic discount
AnalystHighTarget Fair Value